Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402792 · ClinicalTrials.gov registry record · Phase 3
A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following Bunionectomy
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
NCT00402792 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 150 participants.
The verdict
NCT00402792, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of Extended-Release Hydrocodone/Acetaminophen compared to placebo over a 48 hour dosing period in patients who have had bunionectomy surgery and to assess the safety of the drug for 7 days after patients are discharged from the hospital.
Interventions
- DRUG Placebo
- DRUG Hydrocodone/Acetaminophen Extended Release
- DRUG Hydrocodone/Acetaminophen Extended-Release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2006-12 |
| Est. Completion | 2007-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00402792
The ClinicalTrials.gov registry entry for NCT00402792 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00402792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00402792 about?
NCT00402792 is a clinical study titled "A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following Bunionectomy". The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of Extended-Release Hydrocodone/Acetaminophen compared to placebo over a 48 hour dosing period in patients who have had bunionectomy surgery and to assess the safety of the drug for 7 ...
What is the current status of trial NCT00402792?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2006-12. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00402792?
The interventions under investigation include: Placebo (DRUG), Hydrocodone/Acetaminophen Extended Release (DRUG), Hydrocodone/Acetaminophen Extended-Release (DRUG).
Who is sponsoring clinical trial NCT00402792?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.